Overview

Global Regenerative Medicine Market is estimated to value over USD 39.1 billion by 2026 end and register a CAGR of over 22.7% during the forecast period 2019 to 2026.

 

A growing emphasis on stem cells and increasing research and development activities in developing nations are predicted to boost the global regenerative medicine market growth. The emerging economies are focused on advancements in technology, which is predicted to propel market proliferation worldwide. Although, high treatment costs using regenerative medicine, strict regulations by the government and inefficiency in various operations and are projected to impede the market growth.

 

The dermatology segment dominated the dominate with respect to the generation of revenue in 2018. This subjugation can be credited to this largest global regenerative medicine market share that includes the easy availability of grafting methods for treating skin wounds and diseases. A substantial number of Food and Drug Administration (FDA) approved products for healing wounds are available for clinical applications over the last ten years.

Additionally, different advanced approaches in initial phases of development endorse tissue engineering. This includes the usage of drug delivery systems and biomaterials, which influence the replication of cells and control and stimulate the immune system.  Increased complications of the process of wound healing with adverse diseases, for instance, HIV and diabetes have motivated research and development activities assisting the segment growth.

Major players equipped with novel technologies provide manufacturing, management, engineering, quality control services and characterization along with other facilities for researches related to the development of therapies of regeneration and clinical trials. Therefore, with a rise in clinical trials and research and development activities of regenerative medicines, the services segment is predicted to exhibit growth at a soaring rate.

 

Key market players included in the global regenerative medicine industry are Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Spark Therapeutics, Osiris Therapeutics, Kite Pharma, Organogenesis.

regenerative medicines market

Global Regenerative Medicine Market Segmentation:

By Type

  • Cell-Based Immunotherapy & Cell Therapy Products
  • Allogeneic Products
  • Autologous Products
  • Tissue-Engineered Products
  • Gene Therapy Products

 

By Application

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications

 

By Region

 

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

 

Objectives of the Study:

  • To provide with an exhaustive analysis on the global regenerative medicine market by type, by application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics